Thursday, June 25, 2009

Medical News

Medical News


Natural history of lung function described in men and women

Posted: 25 Jun 2009 05:00 PM PDT

Normal lung growth and aging differs between men and women, whereas smoking has a similarly deleterious impact in the two genders, research reveals.

Filaggrin gene variants ‘a risk factor for eczema-associated asthma’

Posted: 25 Jun 2009 05:00 PM PDT

Polymorphisms in the filaggrin gene are the leading genetic contributor to eczema risk and are robust risk factors for asthma occurring in the presence of eczema, a comprehensive analysis has shown.

Sedentary lifestyle ups asthmatics’ healthcare usage

Posted: 25 Jun 2009 05:00 PM PDT

Levels of physical activity are an important determinant of healthcare utilization among adults with asthma, survey results suggest.

Cancer is major cause of death in schizophrenia patients

Posted: 25 Jun 2009 05:00 PM PDT

Cancer is the second most common cause of death in schizophrenia patients after suicide, say researchers who call for greater efforts to improve cancer prevention and early detection in patients with the mental health disorder.

High spring peak in suicide rates among mood disorder patients

Posted: 25 Jun 2009 05:00 PM PDT

The seasonal spring peak in suicide rates is particularly high among patients with a history of mood disorders, research shows.

Infliximab most cost-effective biologic from Swiss healthcare system perspective

Posted: 25 Jun 2009 05:00 PM PDT

The initial biologic given to psoriasis patients in Switzerland should be one with a high response rate, say researchers who found infliximab was a good therapy to start with.

Etanercept at step-down and usual doses improves joint and skin symptoms

Posted: 25 Jun 2009 05:00 PM PDT

New data on the use of etanercept in the treatment of psoriatic arthritis have been presented at the annual meeting of the European League Against Rheumatism in Copenhagen, Denmark.

Fumaric acid esters show promise for chronic plaque psoriasis

Posted: 25 Jun 2009 05:00 PM PDT

Fumaric acid esters are a viable treatment option for patients with severe, treatment-resistant, chronic plaque psoriasis, say researchers.

Hope for more effective pain relief for cancer patients

Posted: 24 Jun 2009 05:00 PM PDT

German researchers have found that two substances released by tumours make nerve cells particularly sensitive, a finding that make lead to the development of novel drugs to block the severe pain often experienced by cancer patients.

Migraines linked to heart attack and stroke risk

Posted: 24 Jun 2009 05:00 PM PDT

Women who suffer from migraines with aura are more likely to have a stroke or heart attack than those who do not experience such headaches, and the association varies with migraine frequency, study results suggest.

Crohn’s disease on the rise in France

Posted: 24 Jun 2009 05:00 PM PDT

Results of a study conducted in northern France show that the incidence of Crohn's disease in the country is increasing, particularly among young people.

Radiotherapy linked to soft tissue cancer risk in breast cancer survivors

Posted: 24 Jun 2009 05:00 PM PDT

Breast cancer patients who receive radiotherapy face an increased risk of developing other soft tissue cancers called sarcomas and should receive regular check-ups for at least 20 years, say US researchers.

DVT risk increases with proximity to major road traffic

Posted: 24 Jun 2009 05:00 PM PDT

Researchers highlight the impact of air pollution on risk for venous thrombosis, finding that living near major roads significantly increases the likelihood of deep vein thrombosis.

Weekly stroke clinic ‘not good enough’ for urgent stroke assessment

Posted: 24 Jun 2009 05:00 PM PDT

An audit published by the UK Royal College of Physicians reveals that weekly outpatient clinics cannot ensure that patients who may have suffered a minor stroke or transient ischemic attack receive urgent evaluation within 1 week, as recommended by the National Clinical Guideline for Stroke.

Prostate biopsy biological features aid tumor prognosis

Posted: 24 Jun 2009 05:00 PM PDT

Biological analysis of diagnostic prostate biopsy, when combined with biomarker information, can accurately predict prostate cancer outcome and may help guide treatment decisions, US study findings suggest.

Prostate cancer fears over botulinum toxin A ‘unfounded’

Posted: 24 Jun 2009 05:00 PM PDT

LNCaP human prostate cancer cell growth is inhibited by botulinum toxin type A, say scientists in findings that suggest the toxin is well tolerated for the treatment of benign prostatic hypertrophy.

Prostate biopsy biological features aid tumor prognosis

Posted: 24 Jun 2009 05:00 PM PDT

Biological analysis of diagnostic prostate biopsy, when combined with biomarker information, can accurately predict prostate cancer outcome and may help guide treatment decisions, US study findings suggest.

Prostate cancer fears over botulinum toxin A ‘unfounded’

Posted: 24 Jun 2009 05:00 PM PDT

LNCaP human prostate cancer cell growth is inhibited by botulinum toxin type A, say scientists in findings that suggest the toxin is well tolerated for the treatment of benign prostatic hypertrophy.

DCIS local recurrence risk independent of age

Posted: 24 Jun 2009 05:00 PM PDT

Young age does not predict a poor outcome after breast-conserving treatment for ductal carcinoma in situ, suggests a US study of local recurrence.

Brucella infection linked with atherogenic lipid profile

Posted: 24 Jun 2009 05:00 PM PDT

Acute infection with Brucella melitensis is associated with an atherogenic lipid profile that remains several months after treatment for the bacterium, a Greek study suggests.

Screening tool could identify new atherosclerosis treatments

Posted: 24 Jun 2009 05:00 PM PDT

A novel screening tool developed by US researchers has identified several compounds that regulate the uptake of oxidized low-density lipoprotein by macrophages, which could help create new treatments for atherosclerosis.

Low-dose pioglitazone beneficial for some Type 2 diabetics

Posted: 24 Jun 2009 05:00 PM PDT

Japanese patients with Type 2 diabetes treated with 7.5 mg a day of pioglitazone show good glycemic control after 12 weeks, study findings show.

Adiponectin strong biomarker of glycemic efficacy

Posted: 24 Jun 2009 05:00 PM PDT

Adiponectin levels are an important predictive biomarker of glycemic control in patients with Type 2 diabetes receiving treatment with peroxisome proliferator-activated receptor agonists, researchers report.

TRANSFER-AMI results supporting early PCI after fibrinolysis published

Posted: 24 Jun 2009 05:00 PM PDT

TRANSFER-AMI results reported in the current issue of the New England Journal of Medicine support a benefit of routine early percutaneous coronary intervention compared with an ischemia-driven strategy after initial fibrinolysis in patients with ST-segment elevation myocardial infarction.

Canadian CV deaths drop overall but proportion in women rises

Posted: 24 Jun 2009 05:00 PM PDT

Hospital admission and death rates for cardiovascular disease dropped by almost a third in Canada over the course of a decade, research shows, but by the start of this century more women than men were dying from the condition.

DCIS local recurrence risk independent of age

Posted: 24 Jun 2009 05:00 PM PDT

Young age does not predict a poor outcome after breast-conserving treatment for ductal carcinoma in situ, suggests a US study of local recurrence.

Prostate brachytherapy survival unaffected by low testosterone

Posted: 23 Jun 2009 05:00 PM PDT

Disease recurrence and overall survival after brachytherapy for prostate cancer are not affected by low pretreatment testosterone levels, US study findings indicate.

Breast intraductal papilloma diagnosed by core needle biopsy requires excision

Posted: 23 Jun 2009 05:00 PM PDT

All patients with intraductal papilloma of the breast diagnosed by core needle biopsy should undergo excision because of the possibility of upstaging to atypia or malignancy, study results suggest.

One-dimensional measurement of breast tumor sufficient for predicting ALN involvement

Posted: 23 Jun 2009 05:00 PM PDT

Three-dimensional measurements of primary breast tumor size are no better at predicting axillary lymph node involvement than the standard one-dimensional maximal tumor diameter, a preclinical study shows.

Adjuvant radiotherapy benefits after prostate cancer surgery confirmed

Posted: 22 Jun 2009 05:00 PM PDT

Adjuvant radiotherapy reduces the risk for biochemical progression in pT3 prostate cancer patients with postoperative undetectable prostate-specific antigen levels, German study findings show.

Prostate cancer prediction improved by PSA derivative analysis

Posted: 22 Jun 2009 05:00 PM PDT

Prostate cancer risk prediction may be improved by calculating prostate-specific antigen derivatives and taking into account the presence of an indwelling transurethral catheter, say German scientists.

Breast cancer outcome not improved by ALND after SN biopsy

Posted: 22 Jun 2009 05:00 PM PDT

Completion axillary lymph node dissection following sentinel lymph node biopsy does not reduce recurrence or increase survival in breast cancer patients compared with SLNB alone, suggests a US analysis published in the Journal of Clinical Oncology.

Pure ductal prostate cancer ‘distinct clinical entity’

Posted: 21 Jun 2009 05:00 PM PDT

Pure ductal prostate adenocarcinoma typically has an indolent clinical course and increased risk for local recurrence, although better post-surgery outcomes, compared with mixed disease, conclude US researchers.

Age influences axillary lymph node involvemen in breast cancer patients

Posted: 21 Jun 2009 05:00 PM PDT

The chances of axillary lymph node involvement in women with breast cancer decrease with increasing age up to around 70 years, after which the risk increases, a Belgian analysis shows.

Sarcoma watch recommended for breast cancer patients

Posted: 21 Jun 2009 05:00 PM PDT

Women with breast cancer who receive radiotherapy or partial mastectomy should receive check-ups for at least 20 years, recommend US researchers on finding these patients have an increased risk for soft tissue sarcomas.

No comments:

Post a Comment